Tandem Diabetes Care (TNDM) had the highest return between January 1, 2018 and June 30, 2018 by a small-cap US stock, returning 837%.
| ASSET | DATE | % RETURN |
|---|---|---|
Tandem Diabetes Care (TNDM) | 1/1/2018 - 6/30/2018 | 837.02% |
Know Labs (KNW) | 1/1/2018 - 6/30/2018 | 338.1% |
BlueLinx (BXC) | 1/1/2018 - 6/30/2018 | 284.14% |
Vaalco Energy (EGY) | 1/1/2018 - 6/30/2018 | 276.55% |
Xpel (XPEL) | 1/1/2018 - 6/30/2018 | 173.57% |
Evolus (EOLS) | 1/1/2018 - 6/30/2018 | 148.8% |
DiaMedica Therapeutics (DMAC) | 1/1/2018 - 6/30/2018 | 125.93% |
Verastem (VSTM) | 1/1/2018 - 6/30/2018 | 121.94% |
WW International, Inc Common Stock (WW) | 1/1/2018 - 6/30/2018 | 119.78% |
Larimar Therapeutics (LRMR) | 1/1/2018 - 6/30/2018 | 119.53% |
OPTIMIZERx (OPRX) | 1/1/2018 - 6/30/2018 | 119.41% |
Regenxbio (RGNX) | 1/1/2018 - 6/30/2018 | 113.54% |
HUYA (HUYA) | 1/1/2018 - 6/30/2018 | 112.19% |
GeoPark (GPRK) | 1/1/2018 - 6/30/2018 | 109.75% |
Semler Scientific (SMLR) | 1/1/2018 - 6/30/2018 | 106% |
Acm Research (ACMR) | 1/1/2018 - 6/30/2018 | 105.33% |
TechTarget, Inc Common Stock (TTGT) | 1/1/2018 - 6/30/2018 | 103.88% |
STAAR Surgical (STAA) | 1/1/2018 - 6/30/2018 | 98.08% |
SurModics (SRDX) | 1/1/2018 - 6/30/2018 | 95.74% |
Spyre Therapeutics (SYRE) | 1/1/2018 - 6/30/2018 | 94.49% |
Zymeworks Inc Common Stock (ZYME) | 1/1/2018 - 6/30/2018 | 92.2% |
Uniqure (QURE) | 1/1/2018 - 6/30/2018 | 90.72% |
BioLife Solutions (BLFS) | 1/1/2018 - 6/30/2018 | 90.17% |
Eyepoint Pharmaceuticals (EYPT) | 1/1/2018 - 6/30/2018 | 89.09% |
Geron (GERN) | 1/1/2018 - 6/30/2018 | 86.41% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
